AMAM

Ambrx Biopharma Inc
AMAM

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

AMAM was delisted on the 6th of March, 2024.

Back to rankings

15 hedge funds and large institutions have $165M invested in Ambrx Biopharma Inc in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.16M
2
+$38K
3
+$3K

Top Sellers

1
-$22.9M
2
-$2.16M
3
-$1.37M
4
OCA
Octagon Capital Advisors
New York
-$1.35M
5
MWNA
Marshall Wace North America
New York
-$640K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$50.3M
2
$33.1M
3
$26.1M
4
$24.7M
5
$11.5M
6
$11.1M
7
$4.72M
8
$1.91M
9
$945K
10
$540K
11
$272K
12
$203K
13
$38K
14
$3K
15
$1K
16
–
17
–
18
–
19
–
20
–
21
–
22
–